Central Serous Chorioretinopathy

This is a condition affecting your eyes. It happens when fluid builds up under the retina, the back part of the eye. This fluid causes a blurry spot or distortion in your vision.

Condition

What people with Central Serous Chorioretinopathy report

Every report comes from a Lived member, sent anonymously.

Have you tried Verteporfin for Central Serous Chorioretinopathy?

NameHow it went

About Central Serous Chorioretinopathy

What It Is

Central serous chorioretinopathy (CSC), also called central serous retinopathy, is an eye condition in which fluid collects under the retina, the light-sensing layer at the back of the eye. The fluid comes from the choroid, a layer of blood vessels beneath the retina, and seeps through a thin supporting layer of cells that normally keeps it out. The result is a small, blister-like lift of the retina, usually right in the macula, the part responsible for sharp central vision. Because the fluid sits in the center, people typically notice blurred, dimmed or distorted central vision in one eye. Straight lines can look bent, objects may seem smaller or farther away than they are, colors can look duller, and there may be a darker patch in the middle of what they see. Side vision is usually unaffected. CSC most often affects one eye at a time, although both can be involved. In many people it clears up on its own, but it can come back, and fluid that lingers for months can leave lasting damage.

Causes & Risk Factors

The exact cause is not fully understood. The choroid in people with CSC tends to be thickened and leaky, and stress hormones appear to play a part. CSC is most common between about 35 and 55 years of age and affects men several times more often than women. Corticosteroids are the best-established risk factor. This includes steroid pills and injections but also inhalers, nasal sprays and skin creams, and even fairly small exposures have been linked to CSC. Other associations include erectile dysfunction medicines such as sildenafil (Viagra), obstructive sleep apnea, high blood pressure, pregnancy, Cushing syndrome (a disorder of excess cortisol, the body's main stress hormone), lupus and organ transplantation. Stressful periods, poor sleep and shift work have also been linked to it. These are associations, not proof that any one factor caused a particular case, and many people with CSC have no obvious trigger.

How It's Diagnosed

CSC is diagnosed by an eye specialist, usually an ophthalmologist. After dilating the pupils with eye drops, the doctor examines the retina and takes detailed images. Optical coherence tomography (OCT) is the key test: a painless scan, similar to taking a photograph, that shows the retina in cross-section so the pocket of fluid can be seen and measured. Repeat OCT scans are also how the doctor tracks whether the fluid is going away. Some people also need fluorescein angiography, in which a dye is injected into an arm vein and photographs show where fluid is leaking, or a related dye test that maps the choroid. These tests help plan laser treatment and rule out conditions that can look similar, such as wet macular degeneration and inflammatory or other causes of fluid under the retina. Because steroid use matters so much, the doctor will ask about every steroid product, including creams, sprays and inhalers, and may consider hormone or sleep problems if other signs point that way.

Treatment Options

For a first episode, the usual approach is to watch and wait. In most acute cases the fluid is reabsorbed on its own within about three to four months, and vision recovers. During that time the eye doctor rechecks the retina with OCT. If a corticosteroid is involved, stopping or lowering it can help the fluid clear, but that decision belongs with the clinician who prescribed it, because the steroid is usually treating another condition that still needs care. Treatment is usually considered when fluid persists beyond a few months, keeps coming back, or when someone needs their vision back quickly, for example because the other eye already sees poorly. The most widely used option is photodynamic therapy (PDT), usually at half the standard dose. A light-sensitive drug, verteporfin (Visudyne), is given through a vein and then activated by a low-energy laser aimed at the leaky choroid. In two randomized trials of longer-lasting CSC, the fluid cleared in roughly 70 to 80 percent of people after PDT, compared with fewer than 30 percent after a type of laser called micropulse laser or after the pill eplerenone. In the United States, verteporfin is approved for other retinal diseases and is used off label for CSC; it also makes the skin and eyes temporarily sensitive to bright light, and availability and insurance coverage can vary. Other options exist. A conventional focal laser can seal a single leak that lies away from the very center of vision, though it can leave a small permanent blind spot where it is applied. Spironolactone and eplerenone, pills normally used for heart and blood pressure conditions, block a hormone receptor thought to be involved in CSC; small studies suggest spironolactone may help, but a larger trial found eplerenone no better than placebo for chronic CSC. Injections into the eye are mainly used if abnormal new blood vessels develop as a complication. It is important to understand the limits of the evidence. Trials have been mostly small, and pooled analyses have not shown that any treatment leads to better long-term vision than the others or than observation. Treatments can speed up drying of the retina, which matters because fluid left in place for a long time can damage it.

What to Expect

Most people with a first episode regain good vision as the fluid clears, typically over a few months. Recovery is not always complete: some notice slight lingering distortion, dimmer colors or reduced contrast even after their scans look normal. While the fluid is present, tasks that rely on sharp central vision, such as reading, driving or detailed work, can be harder, and people often rely more on the unaffected eye. CSC comes back in a substantial share of people, with estimates ranging from about a third to a half, and a new episode can also appear in the other eye. A smaller group develops chronic CSC, in which fluid persists or keeps returning over many months. Chronic CSC is more often seen in older patients and in both eyes, and long-standing fluid can cause permanent loss of central vision. That is why follow-up visits with OCT scans continue until the fluid has cleared and why recurrences are taken seriously. Reviewing steroid use with each prescriber, treating sleep apnea if present, and managing stress and sleep are reasonable steps, although only steroid reduction has consistent evidence behind it.

When to Seek Help

Arrange an eye exam if you notice new blurring, distortion, a dim or dark spot in your central vision, or straight lines that look wavy in one eye. If you have had CSC before, contact your eye doctor when similar symptoms return, since a recurrence may need closer monitoring or treatment, and before starting any steroid treatment so the prescriber knows your history. See an eye doctor the same day for flashes of light, a sudden increase in floaters, or a sudden loss or change of vision. These are not typical of CSC and can signal a more serious retinal problem, such as a tear or detachment.

Questions to Ask Your Doctor

  1. 1.Is this a first, acute episode or a chronic form, and how will that change our plan?
  2. 2.Could any medicine I use, including creams, inhalers or nasal sprays, be contributing, and how should I talk with the prescriber about it?
  3. 3.How long would you watch the fluid before recommending treatment, and which option would you suggest if it does not clear?
  4. 4.How often will I need follow-up scans, and what changes in my vision should prompt me to call sooner?
  5. 5.What is the chance this affects my other eye or comes back, and is there anything I can do to lower that risk?

Last reviewed • Oct 2026

Educational content, not medical advice.